DCBO vs. KXS, LSPD, LWRK, ENGH, CMG, DND, TCS, SYZ, ESP, and ILA
Should you be buying Docebo stock or one of its competitors? The main competitors of Docebo include Kinaxis (KXS), Lightspeed Commerce (LSPD), LifeWorks (LWRK), Enghouse Systems (ENGH), Computer Modelling Group (CMG), Dye & Durham (DND), Tecsys (TCS), Sylogist (SYZ), Brompton Energy Split (ESP), and iLOOKABOUT Corp. (ILA.V) (ILA). These companies are all part of the "software - application" industry.
Kinaxis (TSE:KXS) and Docebo (TSE:DCBO) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, community ranking, profitability, earnings and institutional ownership.
Kinaxis has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, Docebo has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500.
57.4% of Kinaxis shares are owned by institutional investors. Comparatively, 45.2% of Docebo shares are owned by institutional investors. 1.2% of Kinaxis shares are owned by insiders. Comparatively, 43.0% of Docebo shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, Kinaxis had 1 more articles in the media than Docebo. MarketBeat recorded 1 mentions for Kinaxis and 0 mentions for Docebo. Docebo's average media sentiment score of 0.59 beat Kinaxis' score of 0.00 indicating that Kinaxis is being referred to more favorably in the media.
Kinaxis received 437 more outperform votes than Docebo when rated by MarketBeat users. Likewise, 63.31% of users gave Kinaxis an outperform vote while only 59.65% of users gave Docebo an outperform vote.
Docebo has a net margin of 3.55% compared to Docebo's net margin of 3.38%. Kinaxis' return on equity of 5.31% beat Docebo's return on equity.
Kinaxis currently has a consensus price target of C$199.44, indicating a potential upside of 33.81%. Docebo has a consensus price target of C$83.50, indicating a potential upside of 61.20%. Given Kinaxis' higher possible upside, analysts clearly believe Docebo is more favorable than Kinaxis.
Kinaxis has higher revenue and earnings than Docebo. Docebo is trading at a lower price-to-earnings ratio than Kinaxis, indicating that it is currently the more affordable of the two stocks.
Summary
Kinaxis beats Docebo on 11 of the 17 factors compared between the two stocks.
Get Docebo News Delivered to You Automatically
Sign up to receive the latest news and ratings for DCBO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DCBO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
